Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily of cytokines, is one of the most promising candidates for cancer therapeutics. However, many osteosarcomas are resistant to TRAIL. Bisphosphonates are very effective in the treatment of bone proble...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Moon, Myung-Hee, Jeong, Jae-Kyo, Seo, Jae-Suk, Seol, Jae-Won, Lee, You-Jin, Xue, Meilang, Jackson, Christopher J., Park, Sang-Youel
Format: Artigo
Idioma:Inglês
Publicat: Korean Society for Biochemistry and Molecular Biology 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068296/
https://ncbi.nlm.nih.gov/pubmed/21297379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3858/emm.2011.43.3.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars